Handelsbanken Fonder AB Grows Stock Position in Amdocs Limited (NASDAQ:DOX)

Handelsbanken Fonder AB lifted its stake in Amdocs Limited (NASDAQ:DOX) by 6.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 50,115 shares of the technology company’s stock after buying an additional 2,910 shares during the period. Handelsbanken Fonder AB’s holdings in Amdocs were worth $4,267,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Janus Henderson Group PLC increased its holdings in Amdocs by 1.7% during the 3rd quarter. Janus Henderson Group PLC now owns 6,625,875 shares of the technology company’s stock valued at $579,632,000 after purchasing an additional 111,357 shares during the period. Pzena Investment Management LLC increased its holdings in Amdocs by 12.3% during the 3rd quarter. Pzena Investment Management LLC now owns 6,363,739 shares of the technology company’s stock valued at $556,700,000 after purchasing an additional 696,136 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in Amdocs by 2.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,263,591 shares of the technology company’s stock valued at $274,681,000 after purchasing an additional 87,801 shares during the period. Wellington Management Group LLP increased its holdings in Amdocs by 0.8% during the 3rd quarter. Wellington Management Group LLP now owns 2,136,932 shares of the technology company’s stock valued at $186,939,000 after purchasing an additional 16,580 shares during the period. Finally, Pacer Advisors Inc. increased its holdings in Amdocs by 7.4% during the 4th quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company’s stock valued at $154,587,000 after purchasing an additional 125,654 shares during the period. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Stock Down 1.6 %

DOX stock opened at $87.91 on Monday. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $94.04. The business’s 50 day moving average price is $86.07 and its two-hundred day moving average price is $86.66. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The company has a market capitalization of $9.92 billion, a price-to-earnings ratio of 20.40, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. As a group, analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Sunday, April 20th. Stockholders of record on Monday, March 31st will be given a $0.527 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date is Monday, March 31st. Amdocs’s payout ratio is currently 48.72%.

Analysts Set New Price Targets

DOX has been the topic of a number of research analyst reports. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 19th. Barclays reduced their target price on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. Finally, Oppenheimer upped their target price on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.20.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.